A comparison of the orthotic effect of the Odstock Dropped Foot Stimulator and the Walkaide functional electrical stimulation systems on energy cost and speed of walking in Multiple Sclerosis

References

• Multiple Sclerosis Society. A guide to MS for GPs and primary care professionals. 2nd ed. London: Multiple Sclerosis Society; 2009
   Google Scholar
• Pittock SJ, Mayr WT, McClelland RL, et al. Changes in MS-related disability in a population-based cohort: a 10-year follow-up study. Neurology 2004;62:51–9
   PubMed Web of Science ®Google Scholar
• Hobart J, Blight A, Goodman A, et al. Timed 25-foot walk: direct evidence that improving 20% or greater is clinically meaningful in MS. Neurology 2013;80:1509–17
   PubMed Web of Science ®Google Scholar
• Martin CL, Phillips BA, Kilpatrick TJ, et al. Gait and balance impairment in early multiple sclerosis in the absence of clinical disability. Mult Scler 2006;12:620–9
   PubMed Web of Science ®Google Scholar
• Hemmett L, Holmes J, Barnes M, et al. What drives quality of life in multiple sclerosis? Q J Med 2004;97:671–6
   Google Scholar
• Fuhrer MJ. Assessing the efficacy, effectiveness and cost-effectiveness of assistive technology interventions for enhancing mobility. Disabil Rehabil 2007;2:149–58
   Google Scholar
• Kottink AIR, Oostendorp JM, Buurke JH, et al. The orthotic effect of functional electrical stimulation on the improvement of walking in stroke patients with a dropped foot: a systematic review. Artif Organs 2004;28:577–86
   PubMed Web of Science ®Google Scholar
• Stein R, Chong SL, Everaert D, et al. A multicentre trial of a footdrop stimulator controlled by a tilt sensor. Neurorehabil Neural Repair 2006;20:371–9
   PubMed Web of Science ®Google Scholar
• Stein RB, Everaert DG, Thompson AK, et al. Long-term therapeutic and orthotic effects of a foot drop stimulator on walking performance in progressive and nonprogressive neurological disorders. Neurorehabil Neural Repair 2010;24:152–67
   PubMed Web of Science ®Google Scholar
• Taylor PN, Burridge JH, Dunkerley AL, et al. Clinical use of the Odstock dropped foot stimulator: its effect on the speed and effort of walking. Arch Phys Med Rehabil 1999;80:1577–83
   PubMed Web of Science ®Google Scholar
• Paul L, Rafferty D, Young S, et al. The effect of functional electrical stimulation on the physiological cost of gait in people with multiple sclerosis. Mult Scler 2008;14:954–61
   PubMed Web of Science ®Google Scholar
• Barrett CL, Mann GE, Taylor PN, Strike P. A randomized trial to investigate the effects of functional electrical stimulation and therapeutic exercise on walking performance for people with multiple sclerosis. Mult Scler 2009;15:493–503
   PubMed Web of Science ®Google Scholar
• Burridge J, Taylor P, Hagan S, Swain I. Experience of clinical use of the Odstock dropped foot stimulator. Artif Organs 1997;21:254–60
   PubMed Web of Science ®Google Scholar
• Esnouf JE, Taylor PN, Mann GE, et al. Impact on activities of daily living using a functional electrical stimulation device to improve dropped foot in people with multiple sclerosis, measured by the Canadian Occupational Performance Measure. Mult Scler 2010;16:1141–7
   PubMed Web of Science ®Google Scholar
• Centre for Evidence-based Purchasing. Buyers guide: functional electrical stimulation for foot drop of central neurological origin. London: NHS Purchasing & Supply Agency; 2010
   Google Scholar
• Kempen JCE, de Groot V, Knol DL, et al. Community walking can be tested using a 10 meter timed walk test. Mult Scler 2001;17:980–90
   Web of Science ®Google Scholar
• Lord SE, McPherson K, McNaughton HK, et al. Community ambulation after stroke: how important and obtainable is it and what measures are predictive? Arch Phys Med Rehabil 2004;85:234–9
   PubMed Web of Science ®Google Scholar
• Motl RW, Sandroff BM, Suh Y, Sosnoff JJ. Energy cost of walking and its parameters, daily activity and fatigue in persons with mild to moderate Multiple Sclerosis. Neurorehabil Neural Repair 2012;26:1015–21
   PubMed Web of Science ®Google Scholar
• Hauser SL, Dawson DM, Lehrich JR. Intensive immunosuppression in progressive multiple sclerosis: a randomized, 3-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH. N Engl J Med 1983;308:173–80
   PubMed Web of Science ®Google Scholar
• Danielsson A, Sunnerhagen KS. Energy expenditure in stroke subjects walking with a carbon composite ankle foot orthosis. J Rehab Med 2003;36:165–9
   Web of Science ®Google Scholar
• Campbell M, Fitzpatrick R, Haines A, et al. Framework for design and evaluation of complex interventions to improve health. Br Med J 2000;321:694–6
   PubMed Web of Science ®Google Scholar
• Johnston M, Sherer M, Whyte J. Applying evidence standards to rehabilitation research. Am J Phys Med Rehabil 2006;85:292–9
   PubMed Web of Science ®Google Scholar